Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monoaminergic receptors are a broad class of receptors that bind monoamine neurotransmitters and trace amines. These receptors play crucial roles in the nervous system, modulating processes such as emotion, arousal, cognition, attention, and certain types of memory. They are primarily G protein-coupled receptors (GPCRs), with the notable exception of the serotonin 5-HT3 receptor subtype, which is a ligand-gated ion channel. The main classes include adrenergic, dopamine, histamine, melatonin, serotonin, and trace amine-associated receptors (TAARs). Many psychiatric and neurological drugs target monoaminergic systems, and dysregulation of these pathways underlies conditions such as depression, anxiety disorders, schizophrenia, and movement disorders like Parkinson’s disease.
Agonism, Antagonism, Partial agonism, Selective serotonin reuptake inhibition (SSRI), Serotonin-norepinephrine reuptake inhibition (SNRI), Monoamine oxidase inhibition (MAOI)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monoaminergic Receptors (N/A).